University Orthopedics
Characterization of Silver Carboxylate’s Biocompatibility and Efficacy as an Antimicrobial Agent
Wednesday, October 18, 2023
10:53 AM – 10:59 AM PST
Disclosure(s): BI Medical: ownership/equity (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); BioIntraface: ownership/equity (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing)